Cargando…
Endometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model
OBJECTIVES: AL3818 (anlotinib) is a receptor tyrosine kinase inhibitor targeting vascular endothelial growth factor receptors (VEGFR1, VEGFR2/KDR, and VEGFR3), stem cell factor receptor (C-kit), platelet-derived growth factor (PDGFβ), and fibroblast growth factor receptors (FGFR1, FGFR2, and FGFR3)....
Autores principales: | Taurin, Sebastien, Yang, Chieh-Hsiang, Reyes, Maria, Cho, Sungpil, Coombs, Demetrius M., Jarboe, Elke A., Werner, Theresa L., Peterson, C. Matthew, Janát-Amsbury, Margit M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735020/ https://www.ncbi.nlm.nih.gov/pubmed/28953502 http://dx.doi.org/10.1097/IGC.0000000000001129 |
Ejemplares similares
-
An estrogen-induced endometrial hyperplasia mouse model recapitulating human disease progression and genetic aberrations
por: Yang, Chieh-Hsiang, et al.
Publicado: (2015) -
Prior Tubal Ligation Might Influence Metastatic Spread of Nonendometrioid Endometrial Carcinoma
por: Li, Mingxia, et al.
Publicado: (2016) -
The Use of Endometrial Cancer Patient–Derived Organoid Culture for Drug Sensitivity Testing Is Feasible
por: Girda, Eugenia, et al.
Publicado: (2017) -
Increased Association Between Endometriosis and Endometrial Cancer: A Nationwide Population-Based Retrospective Cohort Study
por: Yu, Hann-Chin, et al.
Publicado: (2015) -
Preoperative Tumor Size at MRI Predicts Deep Myometrial Invasion, Lymph Node Metastases, and Patient Outcome in Endometrial Carcinomas
por: Ytre-Hauge, Sigmund, et al.
Publicado: (2015)